₂Haiying Chen

Summary for 2004 [at-glance overview of Haiying Chen work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Haiying Chen. According to available data, in 2004 Haiying Chen published at least 2 articles. This work was completed in collaboration with several authors including Markmann, James F and Trainor, George L. Many other authors have collaborated with Haiying Chen as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Haiying Chen professional interests are focused around "cyclin-dependent kinase inhibitors", "indenopyrazoles cyclin-dependent kinase" and "evaluation indenopyrazoles cyclin-dependent". These might also be referred to as "kinase inhibitors", "nod mice" or "cyclin-dependent kinase". Statistical analysis shows that Haiying Chen's writing is likely to contains terms "nod", "tolerance", "inhibitors", "mice", "resistance" and "kinase".

Unfortunately, there is not enough information to establish Haiying Chen affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Haiying Chen]

Do you know Haiying Chen who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Haiying Chen]

₁₀₂₄Chen, H

Year 2004 Charts [Haiying Chen frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Haiying Chen publication and funding history for the range of years]

Emails (1) [email addresses extracted from Haiying Chen affiliations]

hidden to prevent spam, click here to reveal

Haiying Chen Coauthors (12) [all coauthors with the number of joint publications]

1

1

1

1

1

1

1

₂Koeberlein, Brigitte

1

1

1

1

1

Other [context-specific ads]

Affiliations (2) [condensed summary of the Haiying Chen affiliations, the leading number and the color conveys importance]

₁Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
₁Bristol-Myers Squibb Company, Experimental Station, PO Box 80500, Wilmington, DE 19880-0500, USA.

Key Opinion Leader In [Haiying Chen is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (24) [keywords assigned to Haiying Chen articles by PubMed, the leading number and the color conveys importance]

₁Drug Evaluation, Preclinical | ₁Cell Line, Tumor | ₁Islets of Langerhans Transplantation | ₁Mice | ₁Mice, Inbred NOD | ₁Transplantation, Homologous | ₁Animals | ₁Graft Survival | ₁Enzyme Inhibitors | ₁Species Specificity | ₁Heterocyclic Compounds | ₁Immune Tolerance | ₁Immunosuppressive Agents | ₁Models, Animal | ₁Mice, Inbred C57BL | ₁Humans | ₁Antibodies | ₁Pyrazoles | ₁Fibroblasts | ₁Cyclin-Dependent Kinases | ₁Time Factors | ₁Diabetes Mellitus, Type 1 | ₁Antigens, CD45 | ₁Mice, Inbred C3H

Haiying Chen Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Haiying Chen might be a good expert witness on these terms]

₆nod | ₆tolerance | ₄inhibitors | ₄mice | ₄resistance | ₃kinase | ₃within | ₃strain | ₂changes | ₂evaluation | ₂therapy | ₂induce | ₂cells | ₂compartment | ₂lymphocyte | ₂cell | ₂synthesis | ₂advanced | ₂indenopyrazoles | ₂cyclin-dependent | ₂compound | ₂c3 | ₂activity | ₂involved | ₂heterocycles | ₂anti-cd45rb-induced | ₂part | ₂mechanisms | ₁alloantigen | ₁success | ₁strains | ₁donor-specific
₃kinase inhibitors | ₃nod mice | ₂cyclin-dependent kinase | ₂indenopyrazoles cyclin-dependent | ₂advanced compound | ₂lymphocyte compartment | ₂evaluation indenopyrazoles | ₂changes within | ₂synthesis evaluation | ₂tolerance nod | ₂mechanisms involved | ₂resistance anti-cd45rb-induced | ₂anti-cd45rb-induced tolerance | ₂part heterocycles | ₂mice mechanisms | ₂heterocycles c3 | ₁comparison strain | ₁tumor cells | ₁normal fibroblast | ₁kill normal | ₁c3 part | ₁tolerance induction | ₁contribute mechanism | ₁promising | ₁advances success | ₁must surmounted | ₁fibroblast line | ₁despite robust | ₁cell culture | ₁find | ₁nod-strain mice | ₁action therapy
₂cyclin-dependent kinase inhibitors | ₂indenopyrazoles cyclin-dependent kinase | ₂evaluation indenopyrazoles cyclin-dependent | ₂synthesis evaluation indenopyrazoles | ₂nod mice mechanisms | ₂part heterocycles c3 | ₂anti-cd45rb-induced tolerance nod | ₂mice mechanisms involved | ₂resistance anti-cd45rb-induced tolerance | ₂tolerance nod mice | ₁tolerance induction comparison | ₁compound retains cell | ₁compartment following contact | ₁disclosed analysis cell | ₁kinase inhibitors disclosed | ₁c3 indeno 2-c | ₁allografts c57bl nod-strain | ₁immunological tolerance noted | ₁promising | ₁cyclin dependent kinase | ₁enzyme inhibitors excellent | ₁culture activity presence | ₁protocol remains limited | ₁line ag1523 synthesis | ₁islet transplantation cure | ₁diabetes protocol remains | ₁find | ₁lymphocyte compartment following | ₁must surmounted advanced | ₁cell culture activity | ₁strains defines imposing | ₁advanced compound kill

Reader's Comments (0) [comments posted by readers of Haiying Chen profile]